• EYE-SYNC® by NeuroSync

    EYE-SYNC® by NeuroSync

    EYE-SYNC® technology is a tool that measures the synchronization abilities of the eyes. It is designed to identify the quality of performance when interacting with visual cues and synchronizing eye …

    Published Jan 25, 2023 FDA Breakthrough Device Designation

    Last Updated Jan 25, 2023

  • Koios DS

    Koios DS

    Koios DS is a software that uses artificial intelligence to analyze ultrasound images and provide cancer risk assessments. The software is built on an ensemble of algorithms that have been trained on …

    Published Jan 25, 2023 FDA Breakthrough Device Designation

    Last Updated Jan 25, 2023

  • Agili-C™ by CartiHeal

    Agili-C™ by CartiHeal

    Agili-C™ is a cell-free, off-the-shelf implant that is designed to be used in cartilage and osteochondral defects in traumatic and osteoarthritic joints. The implant is made of a porous, …

    Published Jan 25, 2023 FDA Breakthrough Device Designation

    Last Updated Jan 25, 2023

  • RelieVRx

    RelieVRx

    RelieVRx (formerly EaseVRx) is the first and only FDA-authorized at-home immersive virtual reality (VR) pain treatment indicated as adjunctive treatment for chronic lower back pain (CLBP). RelieVRx is …

    Published Dec 14, 2022 Virtual Reality FDA Breakthrough Device Designation

    Last Updated Jan 25, 2023

  • Vivistim paired VNS system

    Vivistim paired VNS system

    Paired VNS, a treatment for stroke survivors, aims to improve hand and arm function by stimulating the vagus nerve. The vagus nerve, the longest nerve in the body, is responsible for sending messages …

    Published Jan 24, 2023 FDA Breakthrough Device Designation

    Last Updated Jan 24, 2023

  • Paige Prostate Suite

    Paige Prostate Suite

    The Paige Prostate Suite is a set of AI applications designed to assist pathologists in the detection and diagnosis of prostate cancer. The suite includes Paige Prostate Detect, Paige Prostate Grade …

    Published Jan 24, 2023 FDA Breakthrough Device Designation

    Last Updated Jan 24, 2023

  • Canvas Dx™ by Cognoa

    Canvas Dx™ by Cognoa

    Canvas Dx is a software as a medical device (SaMD) that has been authorized by the FDA to aid physicians in diagnosing autism spectrum disorder (ASD) in young children. This technology utilizes …

    Published Jan 24, 2023 FDA Breakthrough Device Designation

    Last Updated Jan 24, 2023

7145 items

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2025 Netspective Foundation, Inc. All Rights Reserved.

Built on Aug 6, 2025 at 3:27pm